Pediatrix Medical GroupFRA:PDC 52 Return-on-Tangible-Asset is 13.57% as of Mar. 2026, which is 78% above its 10-year median of 7.64. GuruFocus rates FRA:PDC with a GF Score™ of 52/100 and a GF Value™ of €11.74 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Pediatrix Medical Group ranks better than 96.05% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Pediatrix Medical Group's annualizedNet Income for the quarter that ended in Mar. 2026 was €102 Mil. Pediatrix Medical Group's average total tangible assets for the quarter that ended in Mar. 2026 was €754 Mil. Therefore, Pediatrix Medical Group's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 13.57%.
The historical rank and industry rank for Pediatrix Medical Group's Return-on-Tangible-Asset or its related term are showing as below:
FRA:PDC'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -71.31 Med: 7.64 Max: 41.06
Current: 20.38
During the past 13 years, Pediatrix Medical Group's highest Return-on-Tangible-Asset was 41.06%. The lowest was -71.31%. And the median was 7.64%.
FRA:PDC's Return-on-Tangible-Asset is ranked better than 96.05% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 2.43
vs FRA:PDC: 20.38
Pediatrix Medical Group (FRA:PDC) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Pediatrix Medical Group Return-on-Tangible-Asset Related Terms
Pediatrix Medical Group Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Pediatrix Medical Group's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pediatrix Medical Group Return-on-Tangible-Asset Chart
FRA:PDC vs SEM, AGL, SGRY: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, Pediatrix Medical Group's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 13.57% mean?
Pediatrix Medical Group (FRA:PDC) has a Return-on-Tangible-Asset of 13.57% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Pediatrix Medical Group and its competitors. This is 78% above median its historical median of 7.64. According to the industry distribution chart, Pediatrix Medical Group ranks #27 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 4%.
Is Pediatrix Medical Group's Return-on-Tangible-Asset too high?
Pediatrix Medical Group's current Return-on-Tangible-Asset of 13.57% is 78% above median its 10-year median of 7.64. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.43. Pediatrix Medical Group's value of 13.57% is 458.4% above this industry median. Based on the distribution chart, Pediatrix Medical Group ranks #27 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pediatrix Medical Group has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's Return-on-Tangible-Asset compare to SEM and AGL?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #27 out of 683 companies for Return-on-Tangible-Asset. This places Pediatrix Medical Group in the top 4% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.43. Pediatrix Medical Group's value of 13.57% is 458.4% above this benchmark. While the company's 10-year median is 7.64 vs. the industry median of 2.43, Pediatrix Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.43, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pediatrix Medical Group's current Return-on-Tangible-Asset of 13.57% is 458.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Pediatrix Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current Return-on-Tangible-Asset is 13.57%, which is 78% above median its own 10-year median of 7.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Pediatrix Medical Group (FRA:PDC) is currently considered Significantly Overvalued. The stock's GF Value™ is €11.74, compared to a current price of €23.40 — trading 99.3% above its estimated fair value. The current Return-on-Tangible-Asset is 13.57%, which is 78% above median its 10-year median of 7.64 and 458.4% above the Healthcare Providers & Services industry median of 2.43. Pediatrix Medical Group's overall GF Score™ is 52/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current Return-on-Tangible-Asset is 13.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of €23.40 is trading 99.3% above its estimated GF Value™ of €11.74.
GuruFocus considers Pediatrix Medical Group to be Significantly Overvalued.
Key valuation signals for FRA:PDC:
Return-on-Tangible-Asset: 13.57% (78% above median its 10-year median of 7.64)
GF Value™: €11.74 vs. price of €23.40 (99.3% above fair value)
Industry Position: 458.4% above the Healthcare Providers & Services median (#27 of 683)
No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
52GF Score
Get the complete analysis for FRA:PDC
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDC has been successfully added to your 
